- Investing Ideas
- /
- U.S. Potentially Undervalued Companies
U.S. Potentially Undervalued Companies
Results
6378
0 new
Companies with a Value score of at least 3, ordered by Value score
6,378 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
EXSR | US$110.00 | 1.1% | 15.2% | US$185.1m | n/a | PB0.7x | n/a | 4.7% | Banks | ||
RIG | US$4.54 | 9.9% | -44.2% | US$4.0b | US$6.81 | PS1.3x | E122.1% | 0% | Energy | ||
LULU | US$262.61 | -1.6% | -32.3% | US$33.2b | US$315.72 | PE19.7x | E7.6% | n/a | Consumer Durables | ||
JBLU | US$5.72 | -3.7% | 26.5% | US$2.0b | US$5.75 | PB0.7x | E88.6% | n/a | Transportation | ||
BKEA.F | HK$1.25 | 4.2% | 2.5% | HK$24.9b | HK$1.25 | PB0.2x | E13.9% | 5.7% | Banks | ||
ERO | CA$21.00 | -0.8% | 19.0% | CA$3.0b | CA$25.93 | PS4.9x | E33.3% | n/a | Materials | ||
PFFV.F | €165.01 | 2.6% | n/a | €1.5b | €172.94 | PE23.9x | n/a | 4.9% | Capital Goods | ||
FNB | US$14.31 | 2.1% | 35.4% | US$5.2b | US$16.56 | PB0.8x | E15.1% | 3.4% | Banks | ||
CWD | US$0.61 | -2.9% | -53.5% | US$14.2m | US$3.50 | PE-1x | E87.0% | n/a | Diversified Financials | ||
LPSN | US$1.06 | -1.9% | -76.1% | US$93.5m | n/a | PB1.4x | E1.7% | n/a | Software | ||
LOW | US$260.14 | 1.9% | 23.6% | US$148.1b | US$255.32 | PE21.3x | E4.6% | 1.8% | Retail | ||
E | €32.05 | 3.6% | -0.9% | €45.3b | €38.02 | PE11.7x | E10.2% | 6.6% | Energy | ||
MAA | US$162.46 | -2.2% | 24.8% | US$19.7b | US$159.27 | PB3.2x | E1.0% | 3.6% | Real Estate | ||
JWCT.F | HK$0.16 | -1.5% | -38.5% | HK$553.8m | n/a | PS2.9x | E-1.8% | n/a | Pharmaceuticals & Biotech | ||
PLYA | US$7.94 | 2.2% | 12.0% | US$1.0b | US$10.50 | PE17.7x | E11.0% | n/a | Consumer Services | ||
PRAX | US$61.51 | 2.7% | 184.8% | US$1.1b | US$146.44 | PS616.7x | E19.2% | n/a | Pharmaceuticals & Biotech | ||
PRQR | US$1.73 | -6.5% | 17.7% | US$145.4m | US$4.13 | PS8x | E-4.6% | n/a | Pharmaceuticals & Biotech | ||
MNDO | US$2.00 | 3.9% | 5.0% | US$40.2m | n/a | PE7.8x | n/a | 12.0% | Software | ||
NESR.F | AU$11.10 | 4.2% | 62.0% | AU$18.4b | AU$11.02 | PE28.8x | E7.9% | 2.5% | Materials | ||
KW | US$10.90 | -4.9% | -28.0% | US$1.5b | US$10.70 | PS3x | n/a | 4.4% | Real Estate Management and Development | ||
CNTB | US$1.23 | 0% | 69.0% | US$68.5m | US$7.00 | PS2.8x | E-15.9% | n/a | Pharmaceuticals & Biotech | ||
PTEN | US$8.37 | 5.8% | -42.2% | US$3.3b | US$13.44 | PE26.5x | E35.5% | 3.8% | Energy | ||
GOCO | US$10.00 | 13.3% | -29.7% | US$230.0m | US$17.67 | PB0.5x | E20.4% | n/a | Insurance | ||
UOLG.Y | S$17.23 | -3.6% | -7.4% | S$4.7b | S$23.71 | PE6.7x | E-31.6% | 3.6% | Real Estate Management and Development |